A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Name: A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
License: Public Domain

Juno Therapeutics, a Subsidiary of Celgene

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lymphoma neoplasms

lymphoma, non-hodgkin, lymphoma, lymphoma, b-cell, lymphoma, large b-cell, diffuse, neoplasms, neoplasms by histologic type

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Related documents